{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-065828","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2026-06-05T20:19:29+00:00","discovered_at":"2026-06-05T20:20:00.248263+00:00","generated_at":"2026-06-05T20:31:55.283406+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Unicycive raises ATM capacity to $150M; files new $50M shelf registration","bullets":["Entered Amendment No. 2 to Sales Agreement with Guggenheim Securities on June 5, 2026.","ATM offering capacity increased from $100M to $150M in aggregate offering price.","Also filed a new S-3 registration statement to sell an additional $50M of common stock.","Previous agreements: initial Sales Agreement Nov 13, 2024; Amendment No. 1 Nov 14, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-065828","json":"https://secwatch.observer/filing/0001213900-26-065828.json","markdown":"https://secwatch.observer/filing/0001213900-26-065828.md","text":"https://secwatch.observer/filing/0001213900-26-065828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/0001213900-26-065828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/ea0291976-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T20:31:55.283406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"31c65a416b3f525a5a673c1688bfccf6ee8babee","claim":"Unicycive Therapeutics, Inc. amended Amendment No. 2 to the Sales Agreement with Guggenheim Securities, LLC (effective 2026-06-05).","evidence_excerpt":"On June 5, 2026, the Company entered into Amendment No. 2 to the Sales Agreement with the Agent (the “Amendment”) to increase the number of Shares that may be sold in the ATM Offering to $150,000,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/0001213900-26-065828-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Guggenheim Securities, LLC"},{"label":"Effective","value":"2026-06-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}